Stoke Therapeutics, Inc. Depreciation
Stoke Therapeutics, Inc. (STOK) reported Depreciation of $897.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-03
- Stoke Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $458.00K, a 2.69% increase year-over-year.
- Stoke Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $439.00K, a 7.97% decline year-over-year.
- Stoke Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $405.00K, a 23.00% decline year-over-year.
- Stoke Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $442.00K, a 18.15% decline year-over-year.
- Stoke Therapeutics, Inc. depreciation for fiscal 2025 was $1.77M, a 18.70% decline from fiscal 2024.
- Stoke Therapeutics, Inc. depreciation for fiscal 2024 was $2.18M, a 11.83% decline from fiscal 2023.
- Stoke Therapeutics, Inc. depreciation for fiscal 2023 was $2.47M, a 59.70% increase from fiscal 2022.
- Stoke Therapeutics, Inc. depreciation for fiscal 2022 was $1.55M, a 58.73% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $897.00K 10-Q · filed 2026-08-03 | $1.30M derived: sum of 3 quarters · filed 2026-08-03 | $1.74M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $439.00K 10-Q · filed 2026-05-07 | $844.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.29M derived: sum of 3 quarters · filed 2026-05-07 | $1.73M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $847.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.29M derived: sum of 3 quarters · filed 2026-08-03 | $1.77M 10-K · filed 2026-03-16 |
| 2025-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $888.00K derived: sum of 2 quarters · filed 2026-08-03 | $1.36M 10-Q · filed 2025-11-04 | $1.89M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $446.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $923.00K 10-Q · filed 2026-08-03 | $1.45M derived: sum of 3 quarters · filed 2026-08-03 | $1.99M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $477.00K 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $1.54M derived: sum of 3 quarters · filed 2026-05-07 | $2.09M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.07M derived: sum of 2 quarters · filed 2026-03-16 | $1.61M derived: sum of 3 quarters · filed 2026-03-16 | $2.18M 10-K · filed 2026-03-16 |
| 2024-09-30 | $540.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.09M derived: sum of 2 quarters · filed 2025-11-04 | $1.65M 10-Q · filed 2025-11-04 | $2.27M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.11M 10-Q · filed 2025-08-12 | $1.74M derived: sum of 3 quarters · filed 2025-08-12 | $2.37M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $563.00K 10-Q · filed 2025-05-13 | $1.19M derived: sum of 2 quarters · filed 2025-05-13 | $1.82M derived: sum of 3 quarters · filed 2025-05-13 | $2.44M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.26M derived: sum of 2 quarters · filed 2025-03-18 | $1.87M derived: sum of 3 quarters · filed 2025-03-18 | $2.47M 10-K · filed 2025-03-18 |
| 2023-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.25M derived: sum of 2 quarters · filed 2024-11-05 | $1.84M 10-Q · filed 2024-11-05 | $2.45M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $611.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.21M 10-Q · filed 2024-08-07 | $1.82M derived: sum of 3 quarters · filed 2024-08-07 | $2.21M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $597.00K 10-Q · filed 2024-05-06 | $1.21M derived: sum of 2 quarters · filed 2024-05-06 | $1.59M derived: sum of 3 quarters · filed 2024-05-06 | $1.90M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $997.00K derived: sum of 2 quarters · filed 2024-03-25 | $1.30M derived: sum of 3 quarters · filed 2024-03-25 | $1.55M 10-K · filed 2024-03-25 |
| 2022-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $690.00K derived: sum of 2 quarters · filed 2023-11-07 | $937.00K 10-Q · filed 2023-11-07 | $1.17M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $549.00K 10-Q · filed 2023-08-07 | $784.00K derived: sum of 3 quarters · filed 2023-08-07 | $1.04M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $247.00K 10-Q · filed 2023-05-04 | $482.00K derived: sum of 2 quarters · filed 2023-05-04 | $736.00K derived: sum of 3 quarters · filed 2023-05-04 | $985.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $489.00K derived: sum of 2 quarters · filed 2023-03-06 | $738.00K derived: sum of 3 quarters · filed 2023-03-06 | $974.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $503.00K derived: sum of 2 quarters · filed 2022-11-14 | $739.00K 10-Q · filed 2022-11-14 | $976.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $485.00K 10-Q · filed 2022-08-08 | $722.00K derived: sum of 3 quarters · filed 2022-08-08 | $956.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $236.00K 10-Q · filed 2022-05-10 | $473.00K derived: sum of 2 quarters · filed 2022-05-10 | $707.00K derived: sum of 3 quarters · filed 2022-05-10 | $931.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $471.00K derived: sum of 2 quarters · filed 2022-03-10 | $695.00K derived: sum of 3 quarters · filed 2022-03-10 | $888.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $458.00K derived: sum of 2 quarters · filed 2021-11-08 | $651.00K 10-Q · filed 2021-11-08 | $790.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $417.00K 10-Q · filed 2021-08-10 | $556.00K derived: sum of 3 quarters · filed 2021-08-10 | $682.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $193.00K 10-Q · filed 2021-05-10 | $332.00K derived: sum of 2 quarters · filed 2021-05-10 | $458.00K derived: sum of 3 quarters · filed 2021-05-10 | $563.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $265.00K derived: sum of 2 quarters · filed 2021-03-09 | $370.00K derived: sum of 3 quarters · filed 2021-03-09 | $450.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $231.00K derived: sum of 2 quarters · filed 2020-11-12 | $311.00K 10-Q · filed 2020-11-12 | $386.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $185.00K 10-Q · filed 2020-08-10 | $260.00K derived: sum of 3 quarters · filed 2020-08-10 | $324.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $80.00K 10-Q · filed 2020-05-15 | $155.00K derived: sum of 2 quarters · filed 2020-05-15 | $219.00K derived: sum of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $139.00K derived: sum of 2 quarters · filed 2020-03-23 | $214.00K 10-K · filed 2020-03-23 | |
| 2018-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $139.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $75.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |